The Clorox Company
CLX
$124.85
$1.751.42%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.64% | -1.98% | 6.17% | -4.01% | 0.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.64% | -1.98% | 6.17% | -4.01% | 0.53% |
| Cost of Revenue | -7.42% | -6.05% | -1.69% | -10.17% | -6.59% |
| Gross Profit | 3.91% | 3.61% | 17.89% | 5.51% | 12.24% |
| SG&A Expenses | -8.46% | -7.51% | -3.42% | -5.62% | 7.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 372.50% | 366.67% | 617.86% | 593.75% | 81.82% |
| Total Operating Expenses | -5.34% | -4.05% | 0.44% | -5.89% | -2.17% |
| Operating Income | 16.37% | 12.45% | 55.62% | 11.19% | 24.72% |
| Income Before Tax | 161.94% | 312.10% | 261.59% | 67.23% | 176.92% |
| Income Tax Expenses | 116.67% | 179.69% | 238.46% | 37.66% | 134.78% |
| Earnings from Continuing Operations | 181.35% | 403.23% | 273.74% | 81.37% | 200.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -25.00% | 15.38% | 0.00% | 0.00% | -20.00% |
| Net Income | 189.17% | 471.25% | 315.12% | 87.92% | 224.32% |
| EBIT | 16.37% | 12.45% | 55.62% | 11.19% | 24.72% |
| EBITDA | 11.55% | 8.55% | 40.89% | 8.66% | 19.41% |
| EPS Basic | 189.29% | 474.73% | 314.50% | 86.94% | 220.90% |
| Normalized Basic EPS | 19.70% | 16.82% | 63.19% | 11.44% | 28.51% |
| EPS Diluted | 189.63% | 487.33% | 325.33% | 88.86% | 225.98% |
| Normalized Diluted EPS | 19.35% | 16.62% | 63.06% | 11.46% | 28.40% |
| Average Basic Shares Outstanding | -0.20% | 0.10% | 0.31% | 0.47% | 0.50% |
| Average Diluted Shares Outstanding | 0.06% | 0.22% | 0.34% | 0.48% | 0.57% |
| Dividend Per Share | 1.67% | 1.67% | 1.68% | 1.69% | 1.69% |
| Payout Ratio | -0.65% | -0.82% | -0.76% | -0.46% | -0.69% |